Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast - Y-mAbs Therapeutics ( NASDAQ:YMAB )

3 weeks ago

NEW YORK, Oct. 25, 2024 ( GLOBE NEWSWIRE ) -- Y-mAbs Therapeutics, Inc. ( the "Company" or "Y-mAbs" ) YMAB, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of ...

Ticker	Sentiment	Impact
YMAB	Neutral	46 %